Pfizer PFIZ34 Balance Sheet

Income Statement

Quarter End	Jul 2022	Oct 2022	Dec 2022	Apr 2023	Jul 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	195.29B	195.35B	197.21B	195.62B	220.17B	215.02B	226.5B	221.1B
Total Current Assets	67.47B	70.4B	51.26B	50.08B	73.35B	74.01B	43.33B	42.41B
Cash and Equivalents	1.78B	1.3B	416M	2.17B	2.63B	3.15B	2.85B	719M
Total Non-Current Assets	143.07B	140.39B	162.22B	162.59B	164.31B	158.87B	202.11B	197.48B
Total Liabilities	107.82B	102.46B	101.29B	94.38B	120.88B	117.82B	137.21B	128.54B
Total Current Liabilities	47.41B	44.31B	42.14B	36.56B	34.65B	31.14B	47.79B	40.5B
Total Non-Current Liabilities	94.71B	90.78B	92.03B	89.52B	147.58B	147.73B	150.96B	149.35B
Common Equity	476M	476M	476M	478M	478M	478M	478M	480M
Retained Earnings	116.61B	122.97B	125.66B	131.1B	128.8B	126.41B	118.35B	121.32B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	171.62B	171.8B	159.42B	167.49B	154.23B	181.48B	197.21B	226.5B
Total Current Assets	38.95B	41.14B	49.93B	32.8B	35.07B	59.69B	51.26B	43.33B
Cash and Equivalents	2.6B	1.34B	1.14B	1.31B	1.78B	1.94B	416M	2.85B
Total Non-Current Assets	59.84B	71.66B	63.76B	63.45B	63.47B	77.46B	95.92B	89.29B
Total Liabilities	111.78B	100.14B	95.66B	104.04B	90.76B	104.01B	101.29B	137.21B
Total Current Liabilities	31.12B	30.43B	31.86B	37.3B	25.92B	42.67B	42.14B	47.79B
Total Non-Current Liabilities	112.06B	103.25B	96.72B	102.69B	101.97B	97.54B	92.03B	150.96B
Total Equity	59.84B	71.66B	63.76B	63.45B	63.47B	77.46B	95.92B	89.29B
Common Equity	485M	485M	486M	485M	470M	473M	476M	478M
Retained Earnings	71.77B	85.29B	89.55B	97.67B	96.77B	103.39B	125.66B	118.35B